← Back to search
BAYSTATE MEDICAL CENTER, INC.
SPRINGFIELD, MA, 01199
UnclaimedClaim this profile (free)
Subcontracting experience
7 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | IVY 5 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 105572 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541715 Parent award performance state: TN Parent award description: SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 View parent award on USAspending | — | $535,000 | Jul 9, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | IVY 5 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 105572 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541715 Parent award performance state: TN Parent award description: SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 View parent award on USAspending | — | $565,000 | Aug 22, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | IVY 5 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 105572 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541715 Parent award performance state: TN Parent award description: SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 View parent award on USAspending | — | $580,000 | Sep 28, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | EVALUATE POST-INTRODUCTION EFFECTIVENESS OF VACCINATION AGAINST LABORATORY-CONFIRMED SYMPTOMATIC, MEDICALLY-ATTENDED SARS-COV-2 AND AGAINST MEDICALLY-ATTENDED INFLUENZA INFECTION WITHIN THE ESTABLISHED CDC INFLUENZA VACCINE EFFECTIVENESS IN CRITICALLY (IVY) NETWORK AND THE HOSPITALIZED ADULT INFLUENZA VACCINE EFFECTIVENESS NETWORK (HAIVEN) ? GOAL IS TO INITIATE ENROLLMENT UPON DIRECTION BY CDC SCIENCE OFFICER BASED ON SUFFICIENT VACCINATION IN TARGET GROUPS (E.G., LONG TERM CARE FACILITY RESIDENTS OR ADULTS >65 YEARS).
PROJECT TITLE IVY 3 - SARS-COV2 ADULT INPATIENT VE CASE CONTROL STUDY 89527 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 622110 Parent award performance state: TN Parent award description: 2021 DOMAIN 1 A008 ADULT INPATIENT & OUTPATIENT VE CASE CONTROL STUDY View parent award on USAspending | HHSD200201691801IUSAspending | $523,060 | Mar 30, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | THE PURPOSE OF THIS CONTRACT IS TO EVALUATE THE EFFECTIVENESS OF VACCINES AGAINST COVID-19, INFLUENZA, AND EVENTUALLY, RSV, AMONG U.S. ADULTS WITH SEVERE ACUTE RESPIRATORY ILLNESS. THE PRIMARY AIM IS TO MONITOR EFFECTIVENESS AGAINST COVID-19-ASSOCIATED AND INFLUENZA-ASSOCIATED HOSPITALIZATIONS, INCLUDING EFFECTIVENESS AGAINST EMERGING VARIANTS OF CONCERN AND DURATION OF PROTECTION. THE CONTRACT WILL ALSO CONDUCT RSV SURVEILLANCE AMONG INPATIENTS WITH ARI AND BUILD ON PRIOR EFFORTS TO UNDERSTAND SEVERE ARI, SEVERITY SCORES, SUSCEPTIBILITY TO INFECTION, MECHANISMS OF DISEASE ATTENUATION, AND VACCINE FAILURES.
PROJECT TITLE IVY4 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 97766 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 622110 Parent award performance state: TN Parent award description: SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 View parent award on USAspending | — | $284,000 | Feb 4, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | EVALUATE POST-INTRODUCTION EFFECTIVENESS OF VACCINATION AGAINST LABORATORY-CONFIRMED SYMPTOMATIC, MEDICALLY-ATTENDED SARS-COV-2 AND AGAINST MEDICALLY-ATTENDED INFLUENZA INFECTION WITHIN THE ESTABLISHED CDC INFLUENZA VACCINE EFFECTIVENESS IN CRITICALLY (IVY) NETWORK AND THE HOSPITALIZED ADULT INFLUENZA VACCINE EFFECTIVENESS NETWORK (HAIVEN) ? GOAL IS TO INITIATE ENROLLMENT UPON DIRECTION BY CDC SCIENCE OFFICER BASED ON SUFFICIENT VACCINATION IN TARGET GROUPS (E.G., LONG TERM CARE FACILITY RESIDENTS OR ADULTS >65 YEARS).
PROJECT TITLE IVY 3 - SARS-COV2 ADULT INPATIENT VE CASE CONTROL STUDY 89527 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 622110 Parent award performance state: TN Parent award description: 2021 DOMAIN 1 A008 ADULT INPATIENT & OUTPATIENT VE CASE CONTROL STUDY View parent award on USAspending | HHSD200201691801IUSAspending | $502,750 | Dec 14, 2021 | — – — |
| Subcontractor | Department of Health and Human Services | BAYSTATE SUBAWARD FOR IVY 2021 - INNOVATIVE METHODS TO EVALUATE THE ROLE OF INFLUENZA VACCINES IN ATTENUATING SEVERE DISEASE IN ADULTS
PROJECT TITLE IVY 2021 - INNOVATIVE METHODS TO EVALUATE THE ROLE OF INFLUENZA VACCINES IN ATTENUATING SEVERE DISEASE IN ADULTS 81576 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 622110 Parent award performance state: TN Parent award description: INNOVATIVE METHODS TO EVALUATE THE ROLE OF INFLUENZA VACCINES IN ATTENUATING SEVERE DISEASE IN ADULTS View parent award on USAspending | — | $325,000 | Nov 3, 2021 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.